CRYOPORT, INC. Shares Outstanding (Cover Page)
CRYOPORT, INC. (CYRX) had Shares Outstanding (Cover Page) of 50.65 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 50.65M shares.
- 2026-04-28: Entity Common Stock, Shares Outstanding 50.40M shares.
- 2026-02-27: Entity Common Stock, Shares Outstanding 49.86M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 50.07M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 50.65M shares 10-Q · filed 2026-08-06 |
| 2026-04-28 | 50.40M shares 10-Q · filed 2026-05-05 |
| 2026-02-27 | 49.86M shares 10-K · filed 2026-03-05 |
| 2025-10-31 | 50.07M shares 10-Q · filed 2025-11-06 |
| 2025-08-08 | 50.07M shares 10-Q · filed 2025-08-12 |
| 2025-04-25 | 50.14M shares 10-Q · filed 2025-05-08 |
| 2025-02-28 | 49.91M shares 10-K · filed 2025-03-07 |
| 2024-10-31 | 49.43M shares 10-Q · filed 2024-11-07 |
| 2024-07-31 | 49.41M shares 10-Q · filed 2024-08-08 |
| 2024-05-01 | 49.26M shares 10-Q · filed 2024-05-08 |
| 2024-02-23 | 48.98M shares 10-K · filed 2024-03-13 |
| 2023-11-03 | 48.96M shares 10-Q · filed 2023-11-09 |
| 2023-07-28 | 48.88M shares 10-Q · filed 2023-08-09 |
| 2023-04-21 | 45.55M shares 10-Q · filed 2023-05-04 |
| 2023-02-17 | 48.34M shares 10-K · filed 2023-02-28 |
| 2022-10-28 | 49.00M shares 10-Q · filed 2022-11-04 |
| 2022-07-29 | 48.49M shares 10-Q · filed 2022-08-04 |
| 2022-04-22 | 49.38M shares 10-Q · filed 2022-05-05 |
| 2022-02-18 | 49.69M shares 10-K · filed 2022-02-28 |
| 2021-10-29 | 46.30M shares 10-Q · filed 2021-11-04 |
| 2021-07-30 | 46.02M shares 10-Q · filed 2021-08-06 |
| 2021-04-23 | 45.68M shares 10-Q · filed 2021-05-06 |
| 2021-02-19 | 45.58M shares 10-K · filed 2021-03-01 |
| 2020-10-30 | 39.66M shares 10-Q · filed 2020-11-06 |
| 2020-07-31 | 38.78M shares 10-Q · filed 2020-08-10 |
| 2020-04-30 | 38.10M shares 10-Q · filed 2020-05-08 |
| 2020-03-01 | 37.64M shares 10-K · filed 2020-03-10 |
| 2019-11-01 | 35.84M shares 10-Q · filed 2019-11-12 |
| 2019-08-02 | 35.59M shares 10-Q · filed 2019-08-09 |
| 2019-04-30 | 30.57M shares 10-Q · filed 2019-05-09 |
| 2019-03-01 | 30.44M shares 10-K · filed 2019-03-13 |
| 2018-10-31 | 29.24M shares 10-Q · filed 2018-11-08 |
| 2018-08-03 | 28.57M shares 10-Q · filed 2018-08-09 |
| 2018-04-30 | 27.68M shares 10-Q · filed 2018-05-03 |
| 2018-03-01 | 27.34M shares 10-K · filed 2018-03-08 |
| 2017-10-31 | 25.54M shares 10-Q · filed 2017-11-02 |
| 2017-07-31 | 24.67M shares 10-Q · filed 2017-08-09 |
| 2017-04-30 | 23.98M shares 10-Q · filed 2017-05-04 |
| 2017-03-01 | 17.60M shares 10-KT · filed 2017-03-13 |
| 2016-11-11 | 17.60M shares 10-Q · filed 2016-11-14 |
| 2016-08-05 | 15.12M shares 10-Q · filed 2016-08-15 |
| 2016-06-13 | 14.27M shares 10-K · filed 2016-06-28 |
| 2016-02-05 | 12.24M shares 10-Q · filed 2016-02-11 |
| 2015-10-30 | 7.23M shares 10-Q · filed 2015-11-16 |
| 2015-07-31 | 7.16M shares 10-Q · filed 2015-08-06 |
| 2015-05-08 | 5.03M shares 10-K · filed 2015-05-19 |
| 2015-01-30 | 60.06M shares 10-Q · filed 2015-02-05 |
| 2014-10-24 | 60.06M shares 10-Q · filed 2014-11-12 |
| 2014-07-25 | 60.04M shares 10-Q · filed 2014-07-31 |
| 2014-06-13 | 59.99M shares 10-K · filed 2014-06-25 |
| 2014-02-07 | 59.45M shares 10-Q · filed 2014-02-13 |
| 2013-11-06 | 58.90M shares 10-Q · filed 2013-11-18 |
| 2013-08-12 | 38.26M shares 10-Q · filed 2013-08-14 |
| 2013-06-17 | 38.26M shares 10-K · filed 2013-06-25 |
| 2013-02-08 | 37.76M shares 10-Q · filed 2013-02-14 |
| 2012-11-02 | 37.76M shares 10-Q · filed 2012-11-09 |
| 2012-08-08 | 37.76M shares 10-Q · filed 2012-08-14 |
| 2012-06-19 | 37.76M shares 10-K · filed 2012-06-27 |
| 2012-02-17 | 28.28M shares 10-Q · filed 2012-02-21 |
| 2011-11-10 | 28.28M shares 10-Q · filed 2011-11-14 |
| 2011-08-15 | 27.95M shares 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |